Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02574676 · ClinicalTrials.gov registry record
Quality of Life (QOL) Registry for Patients With AL Amyloidosis
A clinical trial, sponsored by Prothena Biosciences.
- Completed
- Registry status
- 343
- Enrollment target
NCT02574676 is a clinical trial that has completed, run by Prothena Biosciences. The registered enrollment target is 343 participants.
The verdict
NCT02574676 has completed, sponsored by Prothena Biosciences.
- COMPLETED
- Registry status
- 343 participants
- Enrollment target
Study Summary
This is an online registry to document the psychometric properties of SF-36v2 among patients with AL Amyloidosis, to document patients' burden of disease, to better understand the patient's experience and to follow quality of life issues using a variety of QOL measures.
Interventions
- OTHER non-interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 343 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02574676
The ClinicalTrials.gov registry entry for NCT02574676 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 343 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prothena Biosciences, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which non-interventional is the first listed.
NCT02574676 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02574676 about?
NCT02574676 is a clinical study titled "Quality of Life (QOL) Registry for Patients With AL Amyloidosis". This is an online registry to document the psychometric properties of SF-36v2 among patients with AL Amyloidosis, to document patients' burden of disease, to better understand the patient's experience and to follow quality of life issues using a variety of QOL measures.
What is the current status of trial NCT02574676?
This trial is currently completed. The enrollment target is 343 participants. The study started on 2015-10. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02574676?
The interventions under investigation include: non-interventional (OTHER).
Who is sponsoring clinical trial NCT02574676?
This trial is sponsored by Prothena Biosciences, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.